
Sign up to save your podcasts
Or
Dr Tiffany Richards from The University of Texas MD Anderson Cancer Center in Houston discusses the current and emerging role of bispecific antibodies in the treatment of multiple myeloma.
NCPD information and select publications here.
Dr Tiffany Richards from The University of Texas MD Anderson Cancer Center in Houston discusses the current and emerging role of bispecific antibodies in the treatment of multiple myeloma.
NCPD information and select publications here.
17 Listeners
32 Listeners
14 Listeners
64 Listeners
4 Listeners
2 Listeners
13 Listeners
71 Listeners
1 Listeners
111 Listeners